期刊文献+

脓毒症家兔胰岛组织损伤与血糖变化的研究 被引量:1

下载PDF
导出
摘要 目的:通过制备脓毒症家兔模型,研究其血糖变化与胰腺组织的病理改变之间的关系,探讨脓毒症高血糖的发生机制。方法选择6~8周龄1.7kg左右的清洁级新西兰家兔,用产CTX2M214型超广谱β2内酰胺酶大肠杆菌菌液静脉注射制备动物模型;对模型组和非模型组(正常组)家兔进行危重评分,监测48h内血糖、分析胰腺病理变化。结果(1)模型组的危重评分随时间进展逐渐升高,8h达峰值,之后开始逐渐下降,48h后仍高于注射菌液后2h水平;(2)模型组的血糖水平在最初4h内出现下降趋势,最低值(2.13±0.31)mmol/L,但8h后血糖水平升高,12h达峰值(12.27±2.40)mmol/L,至48h一直维持在较高值,明显高于正常组(P〈0.05);(3)模型组4h、8h、48h胰腺组织病理损害评分分别为(5.17±0.75)分、(8.17±0.29)分、(13.67±0.76)分,较正常组的(0.38±0.48)分明显升高,表明对胰腺组织有损害,且随时间进展损害程度加重。结论脓毒症家兔高血糖发生与胰岛细胞损伤同时发生,胰岛素分泌相对不足可能是引起应激性高血糖发生的关键因素。 ObjectiveTo observe the blood glucose and pancreatic tissue pathological change in rabbit model with sepsis,and investigate the mechanism of hyperglycemia in sepsis. Methods6~8 weeks’ New Zealand rabbit about 1.7kg were choosen as the animal model with sepsis through injecting Escherichia Coli bacteria liquid via vein. The models were divided into a normal group and a model group,in order to carry out critically ill score,blood glucose monitoring and the analysis of islet pathological change within 48 hours.ResultsThe critically ill score of model group gradually raised in the progress,and reach the peak at 8h,and then began decreased,but still higher after 48hcompared with the level at 2h after bacteria liquid injected. The blood glucose levels of model group showed a decline trend during the first 4 h,the lowest was 2.13±0.31mmol/L,after 8 h the blood glucose significantly increased and remained at a higher level till 48 h,the peak was 12.27±2.40 mmol/L. That displayed an obvious difference compared with the normal group(P〈0.05). Compared with normal group,islet tissue in model group presented obvious damage and the severity of damage increased with time.ConclusionThe blood glucose change should be related with islet damage in Rabbit with Sepsis,the deficiency of insulin secretion may play a critical role in the mechanism of hyperglycemia.
出处 《浙江临床医学》 2014年第8期1195-1197,共3页 Zhejiang Clinical Medical Journal
基金 广州市科技局科技支撑项目(No.200821-E291)
关键词 脓毒症 高血糖 胰岛组织 Sepsis Hyperglycemia Islet issue
  • 相关文献

参考文献15

  • 1Vanden -Berghe G, Wilmer A, Hermans G, et al.Intensive insuhn therapy in the medical ICU.N EnglJ Med, 2006, 354(5):449-461.
  • 2Schmidt J, Ratmer DW, Lewandrowski K, et al.A better model of acute pancreatitis for evaluating therapy.Ann Surg, 1992, 215(1):44-56.
  • 3Isaji S, Takada T, Kawarada Y, et al JPN Guidelines for the management of acute pancreatitis:surgical managementJ Hepatobihary Panereat Surg, 2006, 13(1):48-55.
  • 4Van-Cromphaut SJ, Vanhorebeek I, Vanden-Berghe G. Glucose metabolism and insuhn resistance in sepsis. Curt Pharm Des, 2008, 14(19): 1887-1899.
  • 5Handta PD, Mayerb K, Ewald N.Exocrine pancreatic involvement incritically ill patients.Curt Opin Clin Nutr Metab Care, 2009, 12(2): 168-174.
  • 6Barreto SG, Carati CJ, Toouli J, et al.The islet-acinar axis of the pancreas: more than just insulin.Am J Physiol Gastrointest Live physiol, 2010, 299(1):G10-G22.
  • 7Evans JL, Goldfine ID, Maddux BA, et al.Oxidative stress and stress- activated signaling pathways:a uniting hypothesis of type 2 diabetes. Endocr Rev, 2002, 23(4):599.
  • 8Fariss MW, Chan CB, Patel M, et al.P, ole of mitochondria in toxic oxidative stress.Mol Interv, 2005, 5(7):94-99.
  • 9刘芳(综述),祝益民(审校),杜玉开(审校).胰酶对危重症患儿胰腺损害的评价[J].中国小儿急救医学,2010,17(6):564-567. 被引量:3
  • 10祝益民.急性危重病患儿胰腺损害的认识[J].中华急诊医学杂志,2010,19(6):568-570. 被引量:2

二级参考文献46

  • 1Jesús Sáez,Juan Martínez,Celia Trigo,José Sánchez-Payá,Luis Compay,Raquel Laveda,Pilar Grió,Cristina García,Miguel Pérez-Mateo.Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis[J].World Journal of Gastroenterology,2005,11(46):7261-7265. 被引量:21
  • 2Dandona P,Mohanty P, Chaudhuri A, et al. Insulin infusion in acute illness. J Clin Invest,2005,115 ( 8 ) : 2069 -2072.
  • 3vlalhotra A. Intensive insulin in intensive care. N Engl J Med, 2006,354(5) :516-518.
  • 4Carlson GL. Huntefian lecture: insulin resistance in human sepsis:implications for the nutrition al and metabolic care of the critically ill surgical patient. Ann R Coll Surg Engl, 2004,86 (2) :75-81.
  • 5Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the criticaUy ill patients. N Engl J Med,2001,345 (19) :1359-1367.
  • 6Faustino EV,Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr,2005,146( 1 ) :30-34.
  • 7Slater A ,Shann F, Pearson G, et al. PIM2 : a revised version of the Paediatric Index of Mortality. Intensive Care Med,2003,29 (2) :278-285.
  • 8Slater A, Shann F, ANZICS Paediatric Study Group. The suitability of the Pediatric Index of Mortality ( PIM), PIM2, the Pediatric Risk of Mortality ( PRISM), and PRISM Ⅲ for monitoring the quality of pediatric intensive care in Australia and New Zealand. Pediatr Crit Care Med,2004,5 (5) : 447 -454.
  • 9Laird AM,Miller PR,Kilgo PD,et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma, 2004,56 (5) :1058-1062.
  • 10Wahl WL,Taddonio M,Maggio PM,et al. Mean glucose values predict trauma patient mortality. J Tranma, 2008,65 ( 1 ) : 42 -47.

共引文献5

同被引文献36

  • 1Dellinger R P, Levy M M, Rhodes A, et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock, 2012[J]. Intens Care Med, 2013, 39(2): 165-228.
  • 2Dellinger R P, Levy M M, Cadet J M, et al. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2008[J]. Crit Care Med, 2008, 36(1):296-327.
  • 3Dellinger R P, Carlet J M, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J]. Intens Care Med, 2004, 30(4):536-555.
  • 4冯慧远,胡敦重,崔云亮,等.不同血糖变异指标在脓毒症患者预后评估中的对比研究[J].中国急救医学,2015,34(1):9-11.
  • 5Van den Berghe G, Wouters P, Weekers F, et al. Intensive in sulin therapy in critically ill patients[J]. N Engl J Med, 2001, 345 (19):1 359-1 367.
  • 6Brunkhorst F M, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis[J]. N Engl J Med, 2008, 358(2):125-139.
  • 7Finfer S, Chittoek D R, Su S Y, et al. Intensive versus con- ventional glucose control in critically ill patients[J]. N Engl J Med, 2009, 360(13):1 283-1 297.
  • 8Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients:a meta-analysis of randomized con- trolled trials[J]. Eur J Intern Med, 2012, 23(6):564-574.
  • 9王其林,温雅丽,邓建军,崔成宏.血必净注射液对脓毒症患者应激性高血糖反应的影响[J].当代医学,2010,16(4):129-130. 被引量:10
  • 10冯文明,鲍鹰,费卯云,唐成武,王耀,王永春,陶玉龙.亚低温治疗对脓毒症高热病人血糖和胰岛素的影响[J].中国中西医结合外科杂志,2010,16(3):368-370. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部